Agilent Technologies, Inc. (NYSE:A) and PREMIER Biosoft today announced that a selection of Agilent’s high-resolution mass spectrometry and liquid chromatography instruments now supports PREMIER Biosoft’s
. The combined analytical strength of Agilent instrumentation and PREMIER Biosoft’s glycan and glycopeptide data analysis software will open up a new level of discovery for researchers studying the biology of disease.
Glycomics is the study of glycome structures (sugars, modified sugars and saccharides) in molecules and organisms, a tangled web of carbohydrates, proteins and lipids that modulate cellular function and play a primary role in the development of cancer, bacterial and viral diseases, and glycan-specific hereditary diseases. These structures are very difficult to study due to their complexity and kinetics.
“Agilent and PREMIER Biosoft are focused on solving the glycan and glycopeptide identification problem in biopharmaceutical analyses,” said PREMIER Biosoft CEO Arun Apte. “Combining our powerful instruments and software will enable researchers to generate, process and analyze highly complex data so they can put it to use in drug development.”
“Used together, our powerful instrumentation and software fulfills a major unmet need for customers in biopharmaceutical research and development laboratories,” said David Edwards, Agilent’s senior director of LC/MS marketing.
For more information on Agilent’s LC/MS solutions, please click
Information on SimGlycan software is available at
Agilent and PREMIER Biosoft also offer a combined hardware-software solution for lipidomics research.
About PREMIER Biosoft
PREMIER Biosoft (
) was founded in 1994. The company is led by computer scientists, statisticians and biologists dedicated to producing cutting-edge intuitive software for research in life sciences. The company’s goal is to study the most recent innovations in life sciences and translate them into software products to aid research. Follow PREMIER Biosoft on Twitter @PREMIERBiosoft and on
About Agilent Technologies
Agilent Technologies Inc. (NYSE:A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at
On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.